Skip to main content

Medications and Mental Health

  • Reference work entry
  • First Online:
Encyclopedia of Primary Prevention and Health Promotion

An early classification of primary prevention distinguishes among primary, secondary, and tertiary forms (Caplan, 1964). Tertiary prevention, or rehabilitation, focuses on reducing severity and discomfort. Secondary prevention focuses on early detection and treatment while primary prevention focuses on reducing incidence. Bloom (1979) stresses the limitations of this conceptual framework of primary prevention, mainly the inability to identify a “precondition” or “cause” in various forms of illness especially mental illness. He describes a paradigm shift which assumes that “we are all variously vulnerable to stressful life events” and that “reducing the incidence of particular stressful life events” becomes the focus of prevention initiatives, thereby eliminating the need to identify a unique cause for each disorder. This paradigm shifts focus from targeting populations with predisposing biopsychosocial risk factors to identifying precipitating factors, thereby distinguishing itself as...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,500.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,799.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abela, J., & Hankin, B. (2008). Cognitive vulnerability to depression in children and adolescents: A developmental psychopathology perspective. In J. Abela & B. Hankin (Eds.), Handbook of depression in children and adolescents (pp. 35–78). New York: The Guilford Press.

    Google Scholar 

  • American Academy of Child and Adolescent Psychiatry. (2009). Practice parameters on the use of psychotropic medication in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 48(9), 961–973.

    Google Scholar 

  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th text revision [DSM IV-TR] ed). Washington, DC: American Psychiatric Publishing.

    Google Scholar 

  • Amminger, G. P., Schafer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., et al. (2010). Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: A randomized, placebo-controlled trial. Archives of General Psychiatry, 67(2), 146–154.

    PubMed  CAS  Google Scholar 

  • Andersen, S. L., & Teicher, M. H. (2008). Stress, sensitive periods and maturational events in adolescent depression. Trends in Neuroscience, 31(4), 183–191.

    CAS  Google Scholar 

  • Asarnow, J., Jaycox, L., Duan, N., LaBorde, A., Rea, M., Murray, P., et al. (2005). Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: A randomized controlled trial. Journal of the American Medical Association, 293, 311–319.

    PubMed  CAS  Google Scholar 

  • Barkley, R. (1997). Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin, 121(1), 65–94.

    PubMed  CAS  Google Scholar 

  • Bhagwagar, Z., Wylezinska, M., Taylor, M., Jezzard, P., Matthews, P. M., & Cowen, P. J. (2004). Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. American Journal of Psychiatry, 161(2), 368–370.

    PubMed  Google Scholar 

  • Biederman, J., Faraone, S., Milberger, S., Guite, J., Mick, E., Chen, L., et al. (1996). A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Archives of General Psychiatry, 53(5), 437–446.

    PubMed  CAS  Google Scholar 

  • Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999). Pharmacotherapy of attention-deficit hyperactivity disorder reduces risk for substance use disorder. Pediatrics, 104(2), e20–e20.

    PubMed  CAS  Google Scholar 

  • Birmaher, B., Axelson, D., Monk, K., Kalas, C., Clark, D., Ehmann, M., et al. (2003). Fluoxetine for the treatment of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 42(4), 415–422.

    PubMed  Google Scholar 

  • Birmaher, B., Ryan, N., Williamson, D., Brent, D., Kaufman, J., Dahl, R., et al. (1996). Childhood and adolescent depression: A review of the past ten years, Part I. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1427–1439.

    PubMed  CAS  Google Scholar 

  • Bloom, B. (1979). Prevention of mental disorders: Recent advances in theory and practice. Community Mental Health Journal, 15(3), 179–191.

    PubMed  CAS  Google Scholar 

  • Brent, D., Poling, K., McKain, B., & Baugher, M. (1993). A psychoeducational program for families of affectively ill children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 32(4), 770–774.

    PubMed  CAS  Google Scholar 

  • Bridge, J., Iyengar, S., Salary, C., Barbe, R., Birmaher, B., Pincus, H., et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. Journal of the American Medical Association, 297, 1683–1696.

    PubMed  CAS  Google Scholar 

  • Brown, R., Amler, R., Freeman, W., Perrin, J., Stein, M., Feldman, H., et al. (2005). Treatment of attention-deficit/hyperactivity disorder: Overview of the evidence. Pediatrics, 115(6), 749–757.

    Google Scholar 

  • Buitelaar, J., & Kooij, J. (2000). Attention deficit hyperactivity disorder (ADHD): Etiology, diagnosis and treatment. Nederlands Tijdschrift voor Geneeskunde, 144(36), 1716–1723.

    PubMed  CAS  Google Scholar 

  • Cannon, T. D., Cornblatt, B., & McGorry, P. (2007). The empirical status of the ultra high-risk (prodromal) research paradigm. Schizophrenia Bulletin, 33(3), 661–664.

    PubMed  PubMed Central  Google Scholar 

  • Caplan, G. (1964). Principles of preventive psychiatry. New York: Basic Books.

    Google Scholar 

  • Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., et al. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTTgene. Science, 301, 386–389.

    PubMed  CAS  Google Scholar 

  • Cohen, J., Mannarino, A., Perel, J., & Staron, V. (2007). A pilot randomized trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 46(7), 811–819.

    PubMed  Google Scholar 

  • Comer, J., Olfson, M., & Mojtaba, R. (2010). National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996–2007. Journal of the American Academy of Child and Adolescent Psychiatry, 49(10), 1001–1010.

    PubMed  PubMed Central  Google Scholar 

  • Costello, E., Farmer, E., Angold, A., Burns, B., & Erkanli, A. (1997). Psychiatric disorders among American Indian and white youth in Appalachia: The great Smoky Mountains study. American Journal of Public Health, 87(5), 827–832.

    PubMed  CAS  PubMed Central  Google Scholar 

  • Curtis, L., & Patel, K. (2008). Nutritional and environmental approaches to preventing and treating autism and Attention Deficit Hyperactivity Disorder (ADHD): A review. The Journal of Alternative and Complementary Medicine, 14(1), 79–85.

    PubMed  Google Scholar 

  • De Bellis, M., Casey, B., Re, D., Birmaher, B., Williamson, D., Thomas, K., et al. (2000). A pilot study of amygdala volumes in pediatric generalized anxiety disorder. Biological Psychiatry, 48(1), 51–57.

    PubMed  Google Scholar 

  • De Koning, M. B. (2009). Early intervention in patients at ultra high risk of psychosis: Benefits and risks. Acta psychiatrica scandinavica, 119(6), 426–442.

    PubMed  Google Scholar 

  • Diamond, G., & Josephson, A. (2005). Family-based treatment research: A 10-year update. Journal of the American Academy of Child and Adolescent Psychiatry, 44(9), 872–887.

    PubMed  Google Scholar 

  • Eaton, W. W., Badawi, M., & Melton, B. (1995). Prodromes and precursors: Epidemiologic data for primary prevention of disorders with slow onset. American Journal of Psychiatry, 152(7), 967–972.

    PubMed  CAS  Google Scholar 

  • Epstein, J., Casey, B., Tonev, S., Davidson, M., Reiss, A., Garrett, A., et al. (2007). ADHD- and medication-related brain activation effects in concordantly affected parent-child dyads with ADHD. Journal of Child Psychology & Psychiatry, and Allied Disciplines, 48(9), 899–913.

    Google Scholar 

  • Famularo, R., Kinscherff, R., & Fenton, T. (1988). Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study. The American Journal of Diseases of Children, 142(11), 1244–1247.

    CAS  Google Scholar 

  • Feldner, M., & Zvolensky, M. (2004). Prevention and anxiety psychopathology: A critical review of the empirical literature. Clinical Psychology: Science and Practice, 11(4), 405–424.

    Google Scholar 

  • Flannery-Schroeder, E. (2006). Reducing anxiety to prevent depression. American Journal of Preventive Medicine, 6(1), 136–142.

    Google Scholar 

  • Garber, J., Clarke, G., Weersing, V., Beardslee, W., Brent, D., Gladstone, T., et al. (2009). Prevention of depression in at-risk adolescents: A randomized controlled trial. Journal of the American Medical Association, 301(21), 2215–2224.

    PubMed  CAS  PubMed Central  Google Scholar 

  • Geller, D., Hoog, S., Heiligenstein, J., Ricardi, R., Tamura, R., Kluszynski, S., et al. (2001). Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40(7), 773–779.

    PubMed  CAS  Google Scholar 

  • Ginsburg, G., Kendall, P., Sakolsky, D., Compton, S., Piacentini, J., Albano, A., et al. (2011). Remission after acute treatment in children and adolescents with anxiety disorders: Findings from the CAMS. Journal of Consulting and Clinical Psychology, 79(6), 806–813.

    PubMed  PubMed Central  Google Scholar 

  • Goodyear, P., & Hynd, G. (1992). Attention deficit disorder with (ADD/H) and without (ADD/WO) hyperactivity: Behavioral and neuropsychological differentiation. Journal of Clinical Child Psychology, 21(3), 273–305.

    Google Scholar 

  • Goodyer, I., Dubicka, B., Wilkinson, P., Kelvin, R., Roberts, C., Byford, S., et al. (2007). Selective serotonin reuptake inhibitors (SSRI’s) and routine specialist care with and without cognitive behavior therapy in adolescents with major depression: Randomized controlled trial. British Medical Journal, 335(7611), 142–146.

    PubMed  CAS  PubMed Central  Google Scholar 

  • Grady, D., Chi, H., Ding, Y., Smith, M., Wang, E., Schuck, S., et al. (2003). High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder. Molecular Psychiatry, 8(5), 536–545.

    PubMed  CAS  Google Scholar 

  • Harmon, R., & Riggs, P. (1996). Clonidine for posttraumatic stress disorder in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 35(9), 1247–1249.

    PubMed  CAS  Google Scholar 

  • Herman-Stahl, M., Krebs, C., Kroutil, L., & Heller, D. (2006). Risk and protective factors for nonmedical use of prescription stimulants and methamphetamine among adolescents. Journal of Adolescent Health, 39, 374–380.

    PubMed  Google Scholar 

  • Hetrick, S., Merry, S., McKenzie, J., Sindahl, P., & Proctor, M. (2009). Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents (review). The Cochrane Collaboration, 1, 1–62.

    Google Scholar 

  • Hughes, C., Emslie, G., Crismon, M., Posner, K., Birmaher, B., Ryan, N., et al. (2007). Texas children’s medication algorithm project: Update from Texas conference panel on medication treatment of childhood major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46(6), 667–686.

    PubMed  Google Scholar 

  • Jain, R., Segal, S., Kollins, S., & Khayrallah, M. (2011). Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 50(2), 171–179.

    PubMed  Google Scholar 

  • Jensen, P. (2000). Current concepts and controversies in the diagnosis and treatment of attention deficit hyperactivity disorder. Current Psychiatry Reports, 2(2), 102–109.

    PubMed  CAS  Google Scholar 

  • Jensen, P., Hinshaw, S., Swanson, J., Greenhill, L., Conners, C., Arnold, L., et al. (2001). Findings from the NIMH multimodal treatment study of ADHD (MTA): Implications and applications for primary care providers. Journal of Developmental and Behavioral Pediatrics, 22(1), 60–73.

    PubMed  CAS  Google Scholar 

  • Kaloyanides, K., McCabe, S., Cranford, J., & Teter, C. (2007). Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: Relationship with age at initiation of prescription stimulants. Pharmacotherapy, 27(5), 666–674.

    PubMed  PubMed Central  Google Scholar 

  • Katusic, S., Barbaresi, W., Colligan, R., Weaver, A., Leibson, C., & Jacobsen, S. (2005). Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: A population-based, birth cohort study. Journal of Child and Adolescent Psychopharmacology, 15(5), 764–776.

    PubMed  Google Scholar 

  • Kessler, R., Avenevoli, S., McLaughlin, K., Green, J., Lakoma, M., Petukhova, M., et al. (2012). Lifetime co-morbidity of DSM-IV disorders in the US national comorbidity survey replication adolescent supplement (NCS-A). Psychological Medicine, 42(09), 1–14.

    Google Scholar 

  • Kessler, R., & Price, R. (1993). Primary prevention of secondary disorders: A proposal and agenda. American Journal of Community Psychology, 21(5), 607–633.

    PubMed  CAS  Google Scholar 

  • Kollins, S., Jain, R., Brams, M., Segal, S., Findling, R., Wigal, S., et al. (2011). Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD. Pediatrics, 127(6), e1406–e1413.

    PubMed  PubMed Central  Google Scholar 

  • Lou, H. (1996). Etiology and pathogenesis of attention-deficit hyperactivity disorder (ADHD): Significance of prematurity and perinatal hypoxic-haemodynamic encephalopathy. Acta Paediatrica, 85(11), 1266–1271.

    PubMed  CAS  Google Scholar 

  • March, J., Biederman, J., Wolkow, R., Safferman, A., Mardekian, J., Cook, E., et al. (1998). Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial. Journal of the American Medical Association, 280(20), 1752–1756.

    PubMed  CAS  Google Scholar 

  • Marshall, M., & Rathbone, J. (2011). Early intervention for psychosis. Schizophrenia Bulletin, 37(6), 1111–1114.

    PubMed  PubMed Central  Google Scholar 

  • May, D., & Kratochvil, C. (2010). Attention-deficit hyperactivity disorder: Recent advances in paediatric pharmacotherapy. Drugs, 70(1), 15–40.

    PubMed  CAS  Google Scholar 

  • McCabe, S., West, B., Teter, C., Ross-Durow, P., Young, A., & Boyd, C. (2011). Characteristics associated with the diversion of controlled medications among adolescents. Drug and Alcohol Dependence, 118, 452–458.

    PubMed  PubMed Central  Google Scholar 

  • McClellan, J., & Werry, J. (1994). American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 33(5), 616–635.

    PubMed  CAS  Google Scholar 

  • McGorry, P. D., Nelson, B., Amminger, G. P., Bechdolf, A., Francey, S. M., Berger, G., et al. (2009). Intervention in individuals at ultra-high risk for psychosis: A review and future directions. Journal of Clinical Psychiatry, 70(9), 1206–1212.

    PubMed  Google Scholar 

  • Merikangas, K., He, J., Brody, D., Fisher, P., Bourdon, K., Koretz, D., et al. (2010a). Prevalence and treatment of mental disorders among U.S. children in the 2001–2004 NHANES. Pediatrics, 125(1), 75–81.

    PubMed  PubMed Central  Google Scholar 

  • Merikangas, K., He, J., Burstein, M., Swanson, S., Avenevoli, S., Cui, L., et al. (2010b). Lifetime prevalence of mental disorders in U.S. adolescents: Results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry, 49(10), 980–989.

    PubMed  PubMed Central  Google Scholar 

  • Merikangas, K., He, J., Burstein, M., Swendsen, J., Avenevoli, S., Case, B., et al. (2011). Service utilization for lifetime mental disorders in U.S. adolescents: Results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). American Academy of Child and Adolescent Psychiatry, 50(1), 32–45.

    Google Scholar 

  • Milham, M., Nugent, A., Drevets, W., Dickstein, D., Leibenluft, E., Ernst, M., et al. (2005). Selective reduction in amygdala volume in pediatric anxiety disorders: A voxel-based morphometry investigation. Biological Psychiatry, 57(9), 961–966.

    PubMed  Google Scholar 

  • Millichap, J. (2008). Etiologic classification of attention-deficit/hyperactivity disorder. Pediatrics, 121(2), 358–365.

    Google Scholar 

  • Molina, B., Hinshaw, S., Swanson, J., Arnold, L., Vitiello, B., Jensen, P., et al. (2009). The MTA at 8 years: Prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child and Adolescent Psychiatry, 48(5), 484–500.

    PubMed  PubMed Central  Google Scholar 

  • Mrezek, P., & Haggerty, R. (1994). Reducing risks for mental disorders: Frontiers for preventive intervention research. Washington, DC: National Academy Press.

    Google Scholar 

  • MTA Cooperative Group. (2004). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics, 113(4), 754–761.

    Google Scholar 

  • Mufson, L., Dortka, K., Wickramaratne, P., Nomura, Y., Olfson, M., & Weissman, M. (2004). A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Archives of General Psychiatry, 61(6), 577–584.

    PubMed  Google Scholar 

  • Nair, V., & Mahadevan, S. (2009). Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD. Journal of Tropical Pediatrics, 55(2), 116–121.

    PubMed  Google Scholar 

  • Olfson, M., Shaffer, D., Marcus, S., & Greenburg, T. (2003). Relationship between antidepressant medication treatment and suicide in adolescents. Archives of General Psychiatry, 60(10), 978–982.

    PubMed  Google Scholar 

  • Paunesku, D., Ellis, J., Fogel, J., Kuwabara, S., Gollan, J., Gladstone, T., et al. (2008). Clusters of behaviors and beliefs predicting adolescent depression: Implications for prevention. Journal of Cognitive and Behavioral Psychotherapies, 8(2), 147–168.

    PubMed  PubMed Central  Google Scholar 

  • Picchioni, M. M., & Murray, R. M. (2007). Schizophrenia. British Medical Journal, 335(7610), 91–95.

    PubMed  PubMed Central  Google Scholar 

  • Pine, D. (2007). Research review: A neuroscience framework for pediatric anxiety disorders. Journal of Child Psychology & Psychiatry, 48(7), 631–648.

    Google Scholar 

  • Quinn, P., & Nadeau, G. (1999). Understanding girls with AD/HD – Part 1 improving the identification of girls with AD/HD. In G. Nadeau, E. Littman, & P. Quinn (Eds.), Understanding girls with ADHD. Silver Spring, MD: Advantage Books.

    Google Scholar 

  • Rains, A., Scahill, L., & Hamrin, V. (2006). Nonstimulant medications for the treatment of ADHD. Journal of Child and Adolescent Psychiatric Nursing, 19(1), 44–47.

    PubMed  Google Scholar 

  • Renaud, J., Brent, D., Baugher, M., Birmaher, B., Kolko, D., & Bridge, J. (1998). Rapid response to psychosocial treatment for adolescent depression: A two-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry, 37(11), 1184–1190.

    PubMed  CAS  Google Scholar 

  • Riddle, M., Reeve, E., Yaryura-Tobias, J., Yang, H., Claghorn, J., & Gaffney, G. (2001). Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 222–229.

    PubMed  CAS  Google Scholar 

  • Risch, N., Herrell, R., Lehner, T., Liang, K., Eaves, L., Hoh, J., et al. (2009). Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression. Journal of the American Medical Association, 301(23), 2462–2471.

    PubMed  CAS  PubMed Central  Google Scholar 

  • Rynn, M., Siqueland, L., & Rickels, K. (2001). Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. American Journal of Psychiatry, 158(12), 2008–2014.

    PubMed  CAS  Google Scholar 

  • Sanford, M., Boyle, M., McCleary, L., Miller, J., Steele, M., Duku, E., et al. (2006). A pilot study of adjunctive family psychoeducation in adolescent major depression: Feasibility and treatment effect. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 386–495.

    PubMed  Google Scholar 

  • Saxe, G., Stoddard, F., Courtney, D., Cunningham, K., Chawla, N., Sheridan, R., et al. (2001). Relationship between acute morphine and the course of PTSD in children with burns. Journal of the American Academy of Child and Adolescent Psychiatry, 40(8), 915–921.

    PubMed  CAS  Google Scholar 

  • Seedat, S., Stein, D., Ziervogel, C., Middleton, T., Kaminer, D., Emsley, R., et al. (2002). Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder. Journal of Child and Adolescent Psychopharmacology, 12(1), 37–46.

    PubMed  Google Scholar 

  • Swanson, J., Kinsbourne, M., Nigg, J., Lanphear, B., Stefanatos, G., Volkow, N., et al. (2007). Etiologic subtypes of attention-deficit/hyperactivity disorder: Brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychology Review, 17(1), 39–59.

    PubMed  Google Scholar 

  • Swanson, J., Kraemer, H., Hinshaw, S., Arnold, L., Conners, C., Abikoff, H., et al. (2001). Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 168–179.

    PubMed  CAS  Google Scholar 

  • Swanson, J., Sunohara, G., Kennedy, J., Regino, R., Fineberg, E., Wigal, T., et al. (1998). Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): A family-based approach. Molecular Psychiatry, 3(1), 38–41.

    PubMed  CAS  Google Scholar 

  • Treatment for Adolescents with Depression Study (TADS) Team, March, J., Silva, S., Curry, J., Wells, K., Fairbank, J., et al., (2009, October). The treatment for adolescents with depression study (TADS): Outcomes over 1 year of naturalistic follow-up. American Journal of Psychiatry, 166, 1141–1149.

    Google Scholar 

  • U.S. Department of Health and Human Services. (1999). Mental health: A report of the surgeon general – Executive summary. Rockville, MD: U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health.

    Google Scholar 

  • Uher, R., & McGuffin, P. (2010). The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression. Molecular Psychiatry, 15, 18–22.

    PubMed  CAS  Google Scholar 

  • van der Meer, F. J., Velthorst, E., Meijer, C. J., Machielsen, M. W., & de Haan, L. (2012). Cannabis use in patients at clinical high risk of psychosis: Impact on prodromal symptoms and transition to psychosis. Current Pharmaceutical Design, 18(32), 5036–5044.

    PubMed  Google Scholar 

  • van Os, J., & Kapur, S. (2009). Schizophrenia. The Lancet, 374(9690), 635–645.

    Google Scholar 

  • van Voorhees, B., Paunesku, D., Kuwabara, S., Basu, A., Gollan, J., Hankin, B., et al. (2008). Protective and vulnerability factors predicting new-onset depressive episode in a representative of U.S. adolescents. The Journal of Adolescent Health, 42(6), 605–616.

    PubMed  Google Scholar 

  • Wang, P., Lane, M., Olfson, M., Pincus, H., Wells, K., & Kessler, R. (2005). Twelve month use of mental health services in the United States: Results from the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 629–640.

    PubMed  Google Scholar 

  • Weersing, V., Iyengar, S., Kolko, D., Birmaher, B., & Brent, D. (2006). Effectiveness of a cognitive-behavioral therapy for adolescent depression: A benchmarking investigation. Behavioral Therapy, 37(1), 36–48.

    Google Scholar 

  • Weissman, M., Pilowsky, P., Wickramaratne, P., Talati, A., Wisniewski, S., Fava, M., et al. (2006). Remissions in maternal depression and child psychopathology: A STAR*D-child report. Journal of the American Medical Association, 22, 1389–1399.

    Google Scholar 

  • Weisz, J., McCarty, C., & Valeri, S. (2006). Effects of psychotherapy for depression in children and adolescents: A meta-analysis. Psychological Bulletin, 132, 132–149.

    PubMed  PubMed Central  Google Scholar 

  • Wilens, T. E., Adamson, J., Monuteaux, M. C., Faraone, S. V., Schillinger, M., Westerberg, D., et al. (2008). Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Archives of Pediatrics and Adolescent Medicine, 162(10), 916–921.

    PubMed  PubMed Central  Google Scholar 

  • Wilens, T., Bukstein, O., Brams, M., Cutler, A., Childress, A., Rugino, T., et al. (2012). A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 51(1), 74–85.

    PubMed  Google Scholar 

  • Zohar, J., Sonnino, R., Juven-Wetzler, A., & Hagit, C. (2009). Can posttraumatic stress disorder be prevented? CNS Spectrum, 14(1), 44–51.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abner Rayapati .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this entry

Cite this entry

Rayapati, A., Venugopalakrishnan, J., Gandham, L., Kanga, F.H., Martin, C.A. (2014). Medications and Mental Health. In: Gullotta, T.P., Bloom, M. (eds) Encyclopedia of Primary Prevention and Health Promotion. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-5999-6_196

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-5999-6_196

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-5998-9

  • Online ISBN: 978-1-4614-5999-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics